IP Verse

Biocon Biologics competitive analysis

Loading summary...

Explore patent oppositions filed by Biocon Biologics against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3883606	Safe And Effective Method Of Treating Ulcerative Colitis With Anti-Il12/Il23 Antibody	JANSSEN BIOTECH	Apr 8, 2024

Explore the latest publications and patents granted to Biocon Biologics, showcasing their recent innovations and technological advancements.

Discover the latest PTAB cases involving Biocon Biologics, highlighting their recent legal challenges and patent disputes.

Last updated on: Oct 26, 2025

Proceeding Number	Filing Date	Petitioner	Respondent	Status
Get alerts for PTAB Cases involving Biocon Biologics
IPR2024-00298	Dec 18, 2023	BIOCON BIOLOGICS	REGENERON PHARMACEUTICALS	Terminated-Adverse Judgment
IPR2023-01444	Nov 22, 2023	BIOCON BIOLOGICS	JANSSEN BIOTECH	Terminated-Settled
IPR2024-00201	Nov 20, 2023	BIOCON BIOLOGICS	REGENERON PHARMACEUTICALS	Terminated-Adverse Judgment

IP litigation analysis comparing Biocon Biologics with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
BIOCON BIOLOGICS	1	-	3	-
JANSSEN BIOTECH	6	20	1	2
REGENERON PHARMACEUTICALS	38	94	9	31